Skip to main content
All lobbying filings

PUBLIC CITIZEN

Lobbying for PUBLIC CITIZEN

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $76,570.00 expenses · posted Apr 9, 2025

Official filing document

 Bills named in this filing 31
  • HR 1507
    U.S. Citrus Protection Act
  • HR 9014
    Affordable Housing and Area Median Income Fairness Act of 2026
  • HR 7528
    GAP Supply Act
  • HR 115
    No Free Rent for Freeloaders Act of 2025
  • HR 277
    Matthew Lawrence Perna Act of 2025
  • HR 357
    Back to Work Act
  • HR 288
    Long Island Sound Restoration and Stewardship Reauthorization Act of 2025
  • HR 890
    Stopping Pharma’s Ripoffs and Drug Savings For All Act
  • HR 7533
    RISE Reauthorization Act of 2026
  • HR 788
    DOE and SBA Research Act
  • HR 3446
    FDIC Board Accountability Act
  • HR 358
    No Corruption in Government Act
  • HR 7198
    Ensuring Access to General Surgery Act of 2026
  • HR 7867
    Infant Formula Safety Modernization Act of 2026
  • HR 8033
    No Harm Data Centers Act
  • HR 9030
    No Immigration Without Assimilation Act of 2026
  • HR 9031
    Young Adult Tax Credit Act
  • HR 9032
    RESTORE Third Spaces Act of 2026
  • HR 9033
    Timely Agreements Act
  • HR 9085
    Tibet Atrocities Determination Act
  • HR 535
    Inaugural Fund Integrity Act
  • HR 2678
    Ellie’s Law
  • HR 22
    SAVE Act
  • HR 3421
    Gunnison Outdoor Resources Protection Act of 2025
  • S 1655
    Protecting Veterans in Crisis Act
  • HR 946
    ORPHAN Cures Act
  • S 652
    Protecting Patients from Deceptive Drug Ads Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S 832
    EPIC Act of 2025
  • HR 1672
    Maintaining Investments in New Innovation Act
  • S 4749
    A bill to amend the Communications Act of 1934 to create a Federal cause of action to address jawboning, and for other …
 Lobbying activity 10
Banking

general banking issues, Defense of CFPB, CRAs for overdraft, payments rule; stablecoin legislation, stablecoin bill.

Budget/Appropriations

FY 2025 appropriations, opposing policy riders in appropriations, opposition to budget reconciliations, continuing resolution.

Civil Rights/Civil Liberties

Introduction Call - Rep. McIver , Rep Lieu re. access to justice, civil justice, Sen. Hickenlooper re. Product Safety.

Consumer Issues/Safety/Products

Regulatory reform, Stop Corporate Capture Act (H.R. 1507), Corner Post Reversal Act (H.R. 9014), Stop Corporate Capture Act (H.R. 1507, S. 4749), Comment Integrity and Management Act of 2024 (H.R. 7528), artificial intelligence safeguards, Regulatory reform, Product Safety , Midnight Rules Relief Act (H.R. 115), regulatory reform, REINS Act (H.R. 277), H.R. 277, H.R. 357, H.R. H.R. 288, H.R. 890, H.R. 7528, H.R. 7533, H.R. 788, H.R. 3446, H.R. 115, H.R. 358, H.R. 7198, H.R. 7867, H.R. 8033, H.R. 9030, H.R. 9031, H.R. 9032, H.R. 9033, H.R. 9085, Green Tape Elimination Act, Stop Corporate Capture Act, Cong. Johnson Staffer re. Access to Justice, GOOD Act, Guidance Clarity Act, SOPRA, Corner Post Reversal Act.

Government Issues

Reauthorize Office of Congressional Ethics (OCE), Communications with Congressional staff about corporate lobbying disclosure, DC statehood (no bill number yet), ETHICS Act, prohibiting congressional stock trading activity (no bill numbers yet), Inaugural Integrity Act (HR 535, S118), Freedom of Information Act reform, ETHICS Act (HR 2678, S 1171), Campaign Finance Disclosure Legislation, Met with House Member staff to discuss, DISCLOSE Act (No number yet), ETHICS Act (No number yet), Presidential Conflict of Interest Act (No number yet), FOIA reform, Discussion about Campaign Finance Disclosure Policy Ideas, SAVE Act (HR22/S128), Drafting memo to House encouraging Campaign Disclosure legislation; Communications with House staff re: potential campaign disclosure legislation.

Health Issues

H.R.3421 & S.1655 - Medicare for All, Medicare For All Health care nominations, Medicare for All Medicare Advantage.

Labor Issues/Antitrust/Workplace

heat stress, OSHA issues.

Pharmacy

anti-obesity medication pricing, HHS secretary nomination, Medicare drug price negotiation, international reference price negotiation price caps, number of drugs negotiated, out of pocket caps, inflation rebates, negotiation delay periods, direct-to-consumer pharmaceutical telehealth; Medicare drug price negotiation; HHS nomination, Deputy HHS Secretary, and CMS nominations, Medicare drug price negotiation, Capping Prescription Costs Act, National Institute for Biomedical Research and Development legislation, Protecting Patients from Deceptive Drug Ads Online Act, H.R. 946 Orphan CURES Act; Medicare drug price negotiation eligibility delay period, S.652 Protecting Patients from Deceptive Drug Ads Online Act, EPIC Act (H.R. 1492 / S. 832), ORPHAN Cures Act (H.R.946), and MINI Act (H.R.1672); Medicare drug price negotiation delay periods and exemptions.

Postal

USPS issues

Taxation/Internal Revenue Code

Direct File, financial transaction tax.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem